Literature DB >> 7940998

Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions.

J Linden1.   

Abstract

In this review, Joel Linden summarizes what is known about a new and intriguing member of the adenosine receptor family, the A3 receptor. This receptor exhibits unusually large differences in structure, tissue distribution and pharmacological properties between species. Rat A3 receptors are resistant to blockade by xanthine antagonists, but human and sheep A3 receptors can be potently blocked by certain xanthines, notably acidic 8-phenylxanthines. One function of the receptor is to facilitate degranulation of mast cells, and a role for mast cells and A3 receptors in mediating myocardial preconditioning has been proposed. Therefore, selective antagonists of A3 receptors have potential for the treatment of allergic, inflammatory and possibly ischaemic disorders.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7940998     DOI: 10.1016/0165-6147(94)90011-6

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  66 in total

1.  Palmitoylation of the recombinant human A1 adenosine receptor: enhanced proteolysis of palmitoylation-deficient mutant receptors.

Authors:  Z Gao; Y Ni; G Szabo; J Linden
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

Review 2.  A(2A) adenosine receptors in human peripheral blood cells.

Authors:  S Gessi; K Varani; S Merighi; E Ongini; P A Borea
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

Review 3.  Mast cells. Receptors, secretagogues, and signaling.

Authors:  Bhavya B Sharma; John R Apgar; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

Review 4.  Xanthines as adenosine receptor antagonists.

Authors:  Christa E Müller; Kenneth A Jacobson
Journal:  Handb Exp Pharmacol       Date:  2011

5.  Molecular mechanisms of A3 adenosine receptor-induced G1 cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: involvement of intrinsic pathway.

Authors:  Mahmoud Aghaei; Mojtaba Panjehpour; Fatemeh Karami-Tehrani; Siamak Salami
Journal:  J Cancer Res Clin Oncol       Date:  2011-08-10       Impact factor: 4.553

Review 6.  Reperfusion injury: does it exist?

Authors:  Garrett J Gross; John A Auchampach
Journal:  J Mol Cell Cardiol       Date:  2006-10-27       Impact factor: 5.000

7.  Discovery of New Human A(2A) Adenosine Receptor Agonists: Design, Synthesis, and Binding Mode of Truncated 2-Hexynyl-4'-thioadenosine.

Authors:  Xiyan Hou; Hea Ok Kim; Varughese Alexander; Kyunglim Kim; Sun Choi; Seul-Gi Park; Jin Hee Lee; Lena S Yoo; Zhan-Guo Gao; Kenneth A Jacobson; Lak Shin Jeong
Journal:  ACS Med Chem Lett       Date:  2010-09-01       Impact factor: 4.345

Review 8.  Adenosine receptors and angiogenesis.

Authors:  John A Auchampach
Journal:  Circ Res       Date:  2007-11-26       Impact factor: 17.367

9.  Overexpression of A(3) adenosine receptors decreases heart rate, preserves energetics, and protects ischemic hearts.

Authors:  Heather R Cross; Elizabeth Murphy; Richard G Black; John Auchampach; Charles Steenbergen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-06-20       Impact factor: 4.733

10.  Characterization of the A2B adenosine receptor from mouse, rabbit, and dog.

Authors:  John A Auchampach; Laura M Kreckler; Tina C Wan; Jason E Maas; Dharini van der Hoeven; Elizabeth Gizewski; Jayashree Narayanan; Garren E Maas
Journal:  J Pharmacol Exp Ther       Date:  2009-01-13       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.